Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 70, 2006 - Issue 4
Journal homepage
118
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Crystallization of Antiangiogenic Kringle V Derived from Human Apolipoprotein A: Crystallization Applied to Purification and Formulation

Kwan-Yub KANGSchool of Life Sciences and Biotechnology, Korea University;Laboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
Jung-Hwan PARKLaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
In-Hwan LIMLaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
Sung-Geun KIMLaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
See-Hyoung PARKLaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
Won-Kyung KIMLaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
Jeong-Woon HONGLaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
Hyun-Kyung YOULaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
,
Kyung-Hwan JUNGLaboratory of Pharmaceutical Technology, Mogam Biotechnology Research Institute
&
Chan-Wha KIMSchool of Life Sciences and Biotechnology, Korea University
 show all
Pages 916-925 | Received 20 Sep 2005, Accepted 28 Nov 2005, Published online: 22 May 2014

  • 1) Ponting, C. P., Marshall, J. M., and Cederholm-Williams, S. A., Plasminogen: a structural review. Blood Coagul. Fibrinolysis, 3, 605–614 (1992).
  • 2) Dominguez, M., Rojas, G., Loyau, S., Bazurco, M., Sorell, L., and Angles-Cano, E., Kringles of the plasminogen-prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a). Biochim. Biophys. Acta, 1548, 72–80 (2001).
  • 3) Li, X., Bokman, A. M., Llinas, M., Smith, R. A., and Dobson, C. M., Solution structure of the kringle domain from urokinase-type plasminogen activator. J. Mol. Biol., 235, 1548–1559 (1994).
  • 4) Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., and Nakamura, T., HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice. Cancer Res., 60, 6737–6743 (2000).
  • 5) Cao, Y., Cao, R., and Veitonmaki, N., Kringle structures and antiangiogenesis. Curr. Med. Chem. Anti-Canc. Agents, 2, 667–681 (2002).
  • 6) Folkman, J., Role of angiogenesis in tumor growth and metastasis. Semin. Oncol., 29, 15–18 (2002).
  • 7) Schulter, V., Koolwijk, P., Peters, E., Frank, S., Hrzenjak, A., Graier, W. F., van Hinsbergh, V. W., and Kostner, G. M., Impact of apolipoprotein (a) on in vitro angiogenesis. Arterioscler. Thromb. Vasc. Biol., 21, 433–438 (2001).
  • 8) Adam, P. D., Pramila, A., Roseanne, B., Jesus, V. S., Carolyn, S., Edward, G., and Walter, J. C., Phase 1 trial result and preclinical studies of recombinant human Angiostatin (rhAngiostatin) and experimental radiation therapy (EBRT), Annual Meeting of American Society of Clinical Oncology (ASCO) Orlando, Florida (2002).
  • 9) Beerepoot, L. V., Witteveen, E. O., Groenewegen, G., Fogler, W. E., Sim, B. K., Sidor, C., Zonnenberg, B. A., Schramel, F., Gebbink, M. F., and Voest, E. E., Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study. Clin. Cancer Res., 9, 4025–4033 (2003).
  • 10) Kim, J. S., Chang, J. H., Yu, H. K., Ahn, J.-H., Yum, J. S., Lee, S. K., Jung, K. H., Park, D. H., Yoon, Y., Byun, S. M., and Chung, S. I., Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein (a). J. Biol. Chem., 278, 29000–29008 (2003).
  • 11) Kim, J. S., Yu, H. K., Ahn, J. H., Lee, H. J., Hong, S. W., Jung, K. H., Chang, S. I., Hong, Y. K., Joe, Y. A., Byun, S. M., Lee, S. K., Chung, S. I., and Yoon, Y., Human apolipoprotein (a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases. Biochem. Biophys. Res. Commun., 313, 534–540 (2004).
  • 12) Cannata, J. J. B., Phosphoenolpyruvate carboxykinase from bakers’ yeast: isolation of the enzyme and study of its physical properties. J. Biol. Chem., 245, 792–798 (1970).
  • 13) Choi, S. H., Kwon, J. H., and Kim, C. W., Microencapsulation of insulin microdrytlas. Biosci. Biotechnol. Biochem., 68, 749–752 (2004).
  • 14) Kwon, J. H., and Kim, C. W., A novel insulin microcrystal preparation using a seed zone method. J. Crystal Growth, 268, 536–543 (2004).
  • 15) Ducrux, A., and Giegé, R., Methods of crystallization. In “Crystallization of Nucleic Acid and Proteins, a Practical Approach,” eds. Ducrux, A., and Giegé, R., Oxford University Press, New York, pp. 73–98 (1992).
  • 16) Yang, M. X., Shenoy, B., Disttler, M., Patel, R., McGrath, M., Pechenov, S., and Margolin, A. L., Crystalline monoclonal antibodies for subcutaneous delivery. Proc. Natl. Acad. Sci. USA, 100, 6934–6939 (2003).
  • 17) Kwon, J. H., Lee, B. H., Lee, J. J., and Kim, C. W., Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery. Eur. J. Pharm. Sci., 22, 107–116 (2004).
  • 18) Lee, M. J., Kwon, J. H., Shin, J. S., and Kim, C. W., Microcrystallization of α-lactalbumin. J. Crystal Growth, in press.
  • 19) Zhu, M., Cheng, J., and Hua, Z. C., Expression of kringle 5 domain of human plasminogen in Pichia pastoris. Prep. Biochem. Biotechnol., 33, 269–281 (2003).
  • 20) Shepard, S. R., Boucher, R., Johnston, J., Boerner, R., Koch, G., Madsen, J. W., Grella, D., Sim, B. K., and Schrimsher, J. L., Large-scale purification of recombinant human angiostatin. Protein Expr. Purif., 20, 216–227 (2000).
  • 21) Shepard, S. R., Boyd, G. A., and Schrimsher, J. L., Routine manufacture of recombinant proteins using expanded bed adsorption chromatography. Bioseparation, 10, 51–56 (2001).
  • 22) Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C., Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76–85 (1985).
  • 23) Jen, A., Madorin, K., Vosbeck, K., Arvinte, T., and Merkle, H. P., Transforming growth factor beta-3 crystals as reservoirs for slow release of active TGF beta-3. J. Control. Release, 78, 25–34 (2002).
  • 24) Mark, L. B., Muppalla, S., Allen, H. P., David, S. M., Ronald, E. C., David, B. F., Amy, L. C., Lynnie, I., and Sharon, R. M., Hybrid insulin cocrystals for controlled release. Nat. Biotechnol., 20, 800–804 (2002).
  • 25) Mochizuki, S., Hamato, N., Hirose, M., Miyano, K., Ohtani, W., Kameyama, S., Kuwae, S., Tokuyama, T., and Ohi, H., Expression and characterization of recombinant human antithrombin III in Pichia pastoris. Protein Expr. Purif., 23, 55–65 (2001).
  • 26) Murasugi, A., and Tohma-Aiba, Y., Characterization of partially truncated human midkine expressed in Pichia pastoris. Biosci. Biotechnol. Biochem., 66, 1295–1300 (2002).
  • 27) Murasugi, A., and Tohma-Aiba, Y., Production of native recombinant human midkine in the yeast, Pichia pastoris. Protein Expr. Purif., 27, 244–252 (2003).
  • 28) Duman, J. G., Miele, R. G., Liang, H., Grella, D. K., Sim, K. L., Castellino, F. J., and Bretthauer, R. K., O-Mannosylation of Pichia pastoris cellular and recombinant proteins. Biotechnol. Appl. Biochem., 28, 39–45 (1998).
  • 29) Asami, Y., Nagano, H., Ikematsu, S., and Murasugi, A., An approach to the removal of yeast specific O-linked oligo-mannoses from human midkine expressed in Pichia pastoris using site-specific mutagenesis. J. Biochem. (Tokyo), 128, 823–826 (2000).
  • 30) Letourneur, O., Gervasi, G., Gaia, S., Pages, J., Watelet, B., and Jolivet, M., Characterization of Toxoplasma gondii surface antigen 1 (SAG1) secreted from Pichia pastoris: evidence of hyper O-glycosylation. Biotechnol. Appl. Biochem., 33 (Pt. 1), 35–45 (2001).
  • 31) Gale, R., Protein crystals. In “Crystallography Made Crystal Clear,” ed. Gale, R., Academic Press, London, pp. 29–44 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.